As the Academic and Corporate Business Development Lead at General Inception, I lean on my 20+ years of experience in bridging the gap between academia and industry, and turning cutting-edge research into novel and impactful products and services. My mission is to partner with inventors, entrepreneurs, and investors to ignite innovation and create transformational companies benefiting society and the environment.
I also serve as the Interim Chief Executive Officer at Regain BioMedicals, a startup developing a novel device to treat essential tremor, a debilitating condition that affects millions of people worldwide. I am responsible for leading the strategic direction, fundraising, and business development of the company, as well as overseeing the clinical trials and regulatory approvals of our patented technology.
I am passionate about bringing breakthrough research tools and biomedical solutions to the market, accelerating discoveries and improving patient outcomes.